These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26537523)

  • 1. Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice.
    Keller GA; Alvarez PA; Ponte ML; Belloso WH; Bagnes C; Sparanochia C; Gonzalez CD; Villa Etchegoyen MC; Diez RA; Di Girolamo G
    Curr Drug Saf; 2016; 11(1):86-98. PubMed ID: 26537523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.
    Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma Concentrations.
    Keller GA; Etchegoyen MC; Fernandez N; Olivera NM; Quiroga PN; Belloso WH; Diez RA; Di Girolamo G
    Curr Drug Saf; 2016; 11(3):206-14. PubMed ID: 26916784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextrophropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels.
    Keller GA; Villa Etchegoyen C; Fernandez N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    J Opioid Manag; 2018; 14(5):335-344. PubMed ID: 30387857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for QTc interval prolongation.
    Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.
    Kannankeril PJ; Norris KJ; Carter S; Roden DM
    Heart Rhythm; 2011 Oct; 8(10):1530-4. PubMed ID: 21420510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
    Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome.
    Castelletti S; Dagradi F; Goulene K; Danza AI; Baldi E; Stramba-Badiale M; Schwartz PJ
    Int J Cardiol; 2018 Sep; 266():89-94. PubMed ID: 29887480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.
    Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
    Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
    Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs.
    Diemberger I; Massaro G; Cubelli M; Rubino D; Quercia S; Martignani C; Ziacchi M; Biffi M; Bernardi A; Cacciari N; Zamagni C; Boriani G
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1001-9. PubMed ID: 26028320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of drug-induced QT interval prolongation in conscious rabbits.
    Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
    J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.